✦ LIBER ✦

Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavirin

✍ Scribed by V. González; E. Padilla; M. Diago; M. D. Giménez; R. Solà; L. Matas; S. Montoliu; R. M. Morillas; C. Pérez; R. Planas

Book ID: 108885791
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 91 KB
Volume: 12
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2005.00628.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: the efficacy

Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3

✍ S. S. Lee; M. Sherman; A. Ramji; S. Greenbloom; M. Elkashab; H. Pluta; N. Hilzen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Hepatitis C virus RNA kinetics during th

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

✍ T. Carlsson; O. Reichard; G. Norkrans; J. Bläckberg; P. Sangfelt; E. Wallmark; O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Factors associated with rapid and early

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

✍ M. Rodriguez-Torres; M. S. Sulkowski; R. T. Chung; F. M. Hamzeh; D. M. Jensen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

The effect of adherence to therapy on su

The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naïve and nonresponder chronic hepatitis C patients

✍ M. Raptopoulou; D. Tsantoulas; I. Vafiadi; I. Ketikoglou; E. Paraskevas; T. Vass 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB